ArticleNeurotoxicity research2014

Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.

Helena Domin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.